lissamine rhodamine b has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beery, E; Fenig, E; Lavie, G; Morgenstern, C; Nordenberg, J; Perlmutter, I; Uziel, O; Weizman, A | 1 |
1 other study(ies) available for lissamine rhodamine b and B16 Melanoma
Article | Year |
---|---|
Anti-proliferative activity of haloperidol in B16 mouse and human SK-MEL-28 melanoma cell lines.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Benzamides; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin D; Cyclin-Dependent Kinase 2; Cyclins; Cytoplasm; Densitometry; DNA Fragmentation; Dopamine Antagonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Haloperidol; Humans; Imatinib Mesylate; Ligands; Lipids; Melanoma; Melanoma, Experimental; Mice; Piperazines; Protein Binding; Pyrimidines; Rhodamines; Spectrometry, Fluorescence; Time Factors | 2005 |